Edwards Lifesciences Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Edwards Lifesciences (EW) PT Raised to $153 at RBC Capital
October 24, 2018 6:59 AM EDTRBC Capital analyst Glenn Novarro raised the price target on Edwards Lifesciences (NYSE: EW) to $153.00 (from $145.00) while maintaining an Outperform rating.
Novarro notes management commentary on 3Q call moderates our 2019 THV growth outlook.
... MoreEdwards Lifesciences (EW) Tops Q3 EPS by 5c, Offers Q4 Guidance
October 23, 2018 4:20 PM EDTEdwards Lifesciences (NYSE: EW) reported Q3 EPS of $1.07, $0.05 better than the analyst estimate of $1.02. Revenue for the quarter came in at $907 million versus the consensus estimate of $928.18 million.
GUIDANCE:
Edwards Lifesciences sees Q4 2018 EPS of $1.05-$1.20, versus the consensus of $1.21.... More
